Tacrolimus. An update of its pharmacology and clinical efficacy in the management of organ transplantation

Drugs
C M SpencerJ C Gillis

Abstract

Tacrolimus (FK 506) has been evaluated as immunosuppressive therapy in patients with a variety of solid organ and other transplants. Extensive data have now confirmed its efficacy as primary or rescue therapy in renal and hepatic transplantation. In prospective and historically controlled studies of primary therapy, tacrolimus generally demonstrated greater efficacy than the conventional formulation of cyclosporin for preventing episodes of acute rejection and allowed reduction of corticosteroid use. Chronic rejection rates were also significantly lower with tacrolimus in a large randomised liver transplantation trial. However, patient and graft survival rates were similar in both treatment groups (although numerically larger in adults with liver transplants). In children, rejection rates and corticosteroid requirements were usually lower with tacrolimus and patient and graft survival were generally similar with the 2 immunosuppressants. The finding of reduced corticosteroid requirements with tacrolimus may be of particular benefit in prepubertal children, who are still growing. A small amount of evidence has also accumulated regarding the use of tacrolimus as primary therapy in patients who have undergone bone marrow or heart ...Continue Reading

Citations

Sep 27, 2000·Journal of Endocrinological Investigation·P Marchetti, R Navalesi
Oct 21, 2000·Bone Marrow Transplantation·D PrzepiorkaK W Chan
Apr 11, 2001·Therapeutic Drug Monitoring·M Macchi-AndansonJ Baulieux
Jul 10, 2001·International Journal of Urology : Official Journal of the Japanese Urological Association·S SatohT Kato
Sep 28, 2002·Transplantation·Michael N TawadrousAntony M Wheatley
Oct 23, 2003·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Heinrich WienekeRaimund Erbel
Mar 17, 2004·Journal of Clinical Periodontology·J S EllisJ M Thomason
May 26, 2007·Paediatric Drugs·Guido Filler
Jan 1, 2010·Clinical Transplantation·Daniela KniepeissKarl-Heinz Tscheliessnigg
Nov 30, 2011·Drug Metabolism and Pharmacokinetics·Kanoko EgashiraIchiro Ieiri
Jul 25, 2013·Transplant International : Official Journal of the European Society for Organ Transplantation·Ajay K IsraniUNKNOWN DeKAF Genomics Investigators
May 27, 2015·European Journal of Clinical Pharmacology·E G QuetglasSilvio Danese
Dec 17, 2015·Molecular Neurobiology·Sheng ChenJianmin Zhang
Jan 10, 2017·Transplant Infectious Disease : an Official Journal of the Transplantation Society·Minkey Wungwattana, Marizela Savic
Feb 9, 2018·Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society·Nailyn RasoolDean M Cestari
Sep 27, 2018·Advanced Materials·Jindao WuGaolin Liang
Feb 27, 2001·Current Opinion in Urology·E Pohanka
Jul 27, 2001·Transplantation·J P SquiffletUNKNOWN European Tacrolimus-MMF Renal Study Group
Jul 17, 2001·Journal of Hematotherapy & Stem Cell Research·A NaglerY Ilan
Aug 26, 1999·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·J BroekroelofsP E de Jong
May 23, 2001·Clinical Pharmacokinetics·P E Wallemacq, R K Verbeeck
Apr 4, 2001·Alimentary Pharmacology & Therapeutics·H SchwrerG Ramadori
Aug 9, 2002·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Teun van Gelder
May 18, 2007·British Journal of Clinical Pharmacology·Hua-Wen XinLei Xiong
Dec 2, 2008·Drug Development and Industrial Pharmacy·Vivek Baban BorhadeChandrashekhar R Barhate
Dec 4, 2004·Clinical Chemistry and Laboratory Medicine : CCLM·Pierre E Wallemacq
Apr 23, 2004·Pharmacogenomics·Hong-Guang XieGrant R Wilkinson
Jul 2, 2005·Expert Opinion on Emerging Drugs·T Jones
Jul 13, 2004·Clinical Pharmacokinetics·Christine E Staatz, Susan E Tett
Sep 24, 2005·Transplantation·Robert S WoodwardDaniel C Brennan
Sep 3, 2010·Journal of Clinical Neuromuscular Disease·Tommaso IannittiBeniamino Palmieri
Oct 22, 2010·Pediatric Transplantation·Beniamino PalmieriLodi Daniele

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.